| . | Total . | Group A . | Group B . | P . |
|---|---|---|---|---|
| (n = 55) . | (n = 28) . | (n = 27) . | ||
| Mortality, n (%) | 5 (9%) | 4 (14%) | 1 (4%) | 0.4 |
| Arrhythmic death | 0 | 0 | 0 | 1 |
| Cardiac death | 0 | 0 | 0 | 1 |
| Non-cardiac death | 5 (9%) | 4 (14%) | 1 (4%) | 0.4 |
| Syncopal recurrence, n (%) | 22 (40%) | 9 (32%) | 13 (48%) | 0.3 |
| Non-neurally mediated profile syncope | 5 (9%) | 5 (18%) | 0 | 0.05 |
| Neurally mediated profile syncope | 15 (27%) | 3 (11%) | 12 (44%) | 0.007 |
| Pseudosyncope | 2 (4%) | 1 (4%) | 1 (4%) | 1 |
| Number of recurrences, n [IQR] | 1 [1–3.5] | 1 [1–1.75] | 2 [1–4] | 0.21 |
| Implantation of devices, n (%) | ||||
| Pacemaker | 1 (2%) | 1 (4%) | 0 | 1 |
| ICD | 3 (5%) | 3 (11%) | 0 | 0.2 |
| ILR | 1 (2%) | 0 | 1 (4%) | 0.5 |
| . | Total . | Group A . | Group B . | P . |
|---|---|---|---|---|
| (n = 55) . | (n = 28) . | (n = 27) . | ||
| Mortality, n (%) | 5 (9%) | 4 (14%) | 1 (4%) | 0.4 |
| Arrhythmic death | 0 | 0 | 0 | 1 |
| Cardiac death | 0 | 0 | 0 | 1 |
| Non-cardiac death | 5 (9%) | 4 (14%) | 1 (4%) | 0.4 |
| Syncopal recurrence, n (%) | 22 (40%) | 9 (32%) | 13 (48%) | 0.3 |
| Non-neurally mediated profile syncope | 5 (9%) | 5 (18%) | 0 | 0.05 |
| Neurally mediated profile syncope | 15 (27%) | 3 (11%) | 12 (44%) | 0.007 |
| Pseudosyncope | 2 (4%) | 1 (4%) | 1 (4%) | 1 |
| Number of recurrences, n [IQR] | 1 [1–3.5] | 1 [1–1.75] | 2 [1–4] | 0.21 |
| Implantation of devices, n (%) | ||||
| Pacemaker | 1 (2%) | 1 (4%) | 0 | 1 |
| ICD | 3 (5%) | 3 (11%) | 0 | 0.2 |
| ILR | 1 (2%) | 0 | 1 (4%) | 0.5 |
| . | Total . | Group A . | Group B . | P . |
|---|---|---|---|---|
| (n = 55) . | (n = 28) . | (n = 27) . | ||
| Mortality, n (%) | 5 (9%) | 4 (14%) | 1 (4%) | 0.4 |
| Arrhythmic death | 0 | 0 | 0 | 1 |
| Cardiac death | 0 | 0 | 0 | 1 |
| Non-cardiac death | 5 (9%) | 4 (14%) | 1 (4%) | 0.4 |
| Syncopal recurrence, n (%) | 22 (40%) | 9 (32%) | 13 (48%) | 0.3 |
| Non-neurally mediated profile syncope | 5 (9%) | 5 (18%) | 0 | 0.05 |
| Neurally mediated profile syncope | 15 (27%) | 3 (11%) | 12 (44%) | 0.007 |
| Pseudosyncope | 2 (4%) | 1 (4%) | 1 (4%) | 1 |
| Number of recurrences, n [IQR] | 1 [1–3.5] | 1 [1–1.75] | 2 [1–4] | 0.21 |
| Implantation of devices, n (%) | ||||
| Pacemaker | 1 (2%) | 1 (4%) | 0 | 1 |
| ICD | 3 (5%) | 3 (11%) | 0 | 0.2 |
| ILR | 1 (2%) | 0 | 1 (4%) | 0.5 |
| . | Total . | Group A . | Group B . | P . |
|---|---|---|---|---|
| (n = 55) . | (n = 28) . | (n = 27) . | ||
| Mortality, n (%) | 5 (9%) | 4 (14%) | 1 (4%) | 0.4 |
| Arrhythmic death | 0 | 0 | 0 | 1 |
| Cardiac death | 0 | 0 | 0 | 1 |
| Non-cardiac death | 5 (9%) | 4 (14%) | 1 (4%) | 0.4 |
| Syncopal recurrence, n (%) | 22 (40%) | 9 (32%) | 13 (48%) | 0.3 |
| Non-neurally mediated profile syncope | 5 (9%) | 5 (18%) | 0 | 0.05 |
| Neurally mediated profile syncope | 15 (27%) | 3 (11%) | 12 (44%) | 0.007 |
| Pseudosyncope | 2 (4%) | 1 (4%) | 1 (4%) | 1 |
| Number of recurrences, n [IQR] | 1 [1–3.5] | 1 [1–1.75] | 2 [1–4] | 0.21 |
| Implantation of devices, n (%) | ||||
| Pacemaker | 1 (2%) | 1 (4%) | 0 | 1 |
| ICD | 3 (5%) | 3 (11%) | 0 | 0.2 |
| ILR | 1 (2%) | 0 | 1 (4%) | 0.5 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
